Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine CandidatesPRNewsWire • 12/30/22
Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2027 and $74.75 Million Public Offering of Common StockPRNewsWire • 12/28/22
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the PlagueThe Motley Fool • 12/16/22
Novavax stock sinks after proposed $125 million share sale, convertible debt offeringMarket Watch • 12/14/22
Is Novavax Stock A Buy On A Vaccines Rally Following Bullish Moderna News?Investors Business Daily • 12/13/22
Nasdaq Bear Market: 3 Remarkable Growth Stocks Down 86% to 95% That Can Double Your Money in 2023The Motley Fool • 12/13/22
Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in AdolescentsPRNewsWire • 12/07/22
Is Novavax Stock A Buy On Its Massive Sales Beat Despite Unexpected Losses?Investors Business Daily • 12/06/22
3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall StreetThe Motley Fool • 12/06/22